BRAIN Biotech AG (FRA:BNN)

Market Cap	48.50M
Revenue (ttm)	53.61M
Net Income (ttm)	-11.70M
Shares Out	n/a
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,512
Open	2.270
Previous Close	2.250
Day's Range	2.240 - 2.270
52-Week Range	1.810 - 4.400
Beta	n/a
RSI	52.57
Earnings Date	Jan 14, 2026

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was forme...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1993
• Employees: 318
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BNN

Financial Performance

In 2024, BRAIN Biotech AG's revenue was 55.50 million, a decrease of -1.29% compared to the previous year's 56.23 million. Losses were -11.13 million, 34.4% more than in 2023.